SMS Lifesciences India Ltd. | Small-cap | Healthcare
₹1,173.10
-0.36%
| SMS Lifesciences Stock Comparison:
SMS Lifesciences vs BioconSMS Lifesciences vs OneSource SpecialtySMS Lifesciences vs Zota Health CareSMS Lifesciences vs Dishman CarbogenSMS Lifesciences vs Panacea BiotecSMS Lifesciences vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 825.0M
Gross Profit 308.6M 37.40%
Operating Income 78.9M 9.56%
Net Income 43.8M 5.31%
EPS (Diluted) ₹13.75

Balance Sheet Metrics

Total Assets 3.9B
Total Liabilities 1.8B
Shareholders Equity 2.1B
Debt to Equity 0.84

Cash Flow Metrics

Revenue & Profitability Trend

SMS Lifesciences Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i3.4B3.0B3.1B3.5B2.6B
Cost of Goods Sold i2.2B2.1B2.3B2.6B1.9B
Gross Profit i1.2B907.7M845.5M875.4M702.1M
Gross Margin % i34.8%30.3%27.1%25.2%27.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i58.5M57.9M54.5M50.3M52.1M
Other Operating Expenses i145.4M77.9M67.6M77.9M97.6M
Total Operating Expenses i203.9M135.8M122.1M128.1M149.8M
Operating Income i301.3M162.8M180.5M246.5M223.9M
Operating Margin % i8.9%5.4%5.8%7.1%8.7%
Non-Operating Items
Interest Income i3.1M2.8M4.0M3.2M4.3M
Interest Expense i84.6M99.5M64.2M57.0M41.6M
Other Non-Operating Income-----
Pre-tax Income i261.9M98.5M165.9M327.3M195.7M
Income Tax i74.6M35.2M52.2M74.3M60.1M
Effective Tax Rate % i28.5%35.7%31.4%22.7%30.7%
Net Income i187.3M63.3M113.8M253.0M135.6M
Net Margin % i5.6%2.1%3.6%7.3%5.3%
Key Metrics
EBITDA i496.1M347.4M314.6M356.6M315.7M
EPS (Basic) i₹66.51₹30.08₹37.92₹83.76₹44.84
EPS (Diluted) i₹66.51₹30.08₹37.92₹83.76₹44.84
Basic Shares Outstanding i30232873023287302328730232873023287
Diluted Shares Outstanding i30232873023287302328730232873023287

Income Statement Trend

SMS Lifesciences Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i5.0M5.7M12.8M9.9M85.4M
Short-term Investments i10.1M9.2M23.3M23.7M20.9M
Accounts Receivable i687.9M513.5M460.6M338.3M341.5M
Inventory i674.0M812.1M862.3M848.1M616.3M
Other Current Assets126.5M211.7M403.1M-1.0K194.4M
Total Current Assets i1.5B1.6B1.6B1.6B1.3B
Non-Current Assets
Property, Plant & Equipment i36.9M42.3M34.5M38.1M25.9M
Goodwill i515.0K495.0K754.0K1.1M340.4M
Intangible Assets i515.0K495.0K754.0K1.1M1.4M
Long-term Investments-----
Other Non-Current Assets38.8M27.3M-18.0K47.7M-2.0K
Total Non-Current Assets i2.4B2.4B2.4B2.0B1.8B
Total Assets i3.9B3.9B3.9B3.6B3.0B
Liabilities
Current Liabilities
Accounts Payable i532.7M591.3M596.7M778.9M611.4M
Short-term Debt i664.0M651.8M442.4M374.1M255.4M
Current Portion of Long-term Debt-----
Other Current Liabilities77.7M98.6M40.0K56.5M167.5M
Total Current Liabilities i1.4B1.4B1.3B1.4B1.1B
Non-Current Liabilities
Long-term Debt i200.1M355.4M562.5M421.9M391.4M
Deferred Tax Liabilities i107.4M120.4M127.6M106.8M108.3M
Other Non-Current Liabilities-1.0K--1.0K-60.0M
Total Non-Current Liabilities i358.8M523.2M731.1M563.8M590.0M
Total Liabilities i1.8B2.0B2.1B1.9B1.7B
Equity
Common Stock i30.2M30.2M30.2M30.2M30.2M
Retained Earnings i1.1B954.1M892.1M788.8M600.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.1B1.9B1.9B1.6B1.3B
Key Metrics
Total Debt i864.1M1.0B1.0B796.0M646.9M
Working Capital i85.1M107.1M255.5M205.8M122.1M

Balance Sheet Composition

SMS Lifesciences Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i261.9M98.5M142.4M200.4M195.7M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-13.8M-35.2M72.5M-554.3M-68.5M
Operating Cash Flow i289.7M124.7M251.1M-320.5M151.3M
Investing Activities
Capital Expenditures i-149.8M-207.4M-428.0M-415.2M-354.7M
Acquisitions i-----
Investment Purchases i---1.2M0-20.2M
Investment Sales i023.3M112.0M337.9M38.1M
Investing Cash Flow i-150.6M-185.3M-314.9M-73.5M-266.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-4.5M-4.5M-4.5M--
Debt Issuance i3.5M0298.1M116.9M67.8M
Debt Repayment i-178.0M-176.2M-114.4M-73.1M-62.7M
Financing Cash Flow i-142.0M-14.3M208.9M130.4M-2.5M
Free Cash Flow i187.1M34.4M-338.6M-623.9M-3.9M
Net Change in Cash i-2.8M-74.9M145.1M-263.6M-117.4M

Cash Flow Trend

SMS Lifesciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 19.70
Price to Book 1.74
Price to Sales 1.02
PEG Ratio -0.49

Profitability Ratios

Profit Margin 5.17%
Operating Margin 9.56%
Return on Equity 9.48%
Return on Assets 5.16%

Financial Health

Current Ratio 1.06
Debt to Equity 40.75
Beta 0.22

Per Share Data

EPS (TTM) ₹57.23
Book Value per Share ₹649.96
Revenue per Share ₹1,106.94

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
smslife3.5B19.701.749.48%5.17%40.75
Biocon 470.2B108.041.923.66%2.44%66.26
OneSource Specialty 212.6B-1,129.083.58-0.31%-0.85%16.03
Zota Health Care 45.3B-70.1218.42-24.83%-17.04%0.61
Dishman Carbogen 44.8B43.200.740.06%3.60%40.97
Panacea Biotec 25.5B215.592.93-1.01%1.88%2.67

Financial data is updated regularly. All figures are in the company's reporting currency.